Are placebo-controlled trials of creams for athlete's foot still justified?

NewsBot · Oct 7, 2008

Members do not see these Ads. Sign Up.
Are placebo-controlled trials of creams for athlete's foot still justified?
Crawford F, Harris R, Williams HC.
Br J Dermatol. 2008 Sep;159(4):773-9.

BACKGROUND: Placebo-controlled trials are useful in identifying effective treatments where none has existed, but their continued use once efficacy is established arguably contravenes ethical standards for medical research.

OBJECTIVES: To consider whether sufficient evidence exists to recommend the abandonment of vehicle-controlled studies in trials of topical treatments for athlete's foot.

METHODS: We searched nine electronic databases and bibliographies of review articles as part of an ongoing Cochrane systematic review from 1966 to 2007. Randomized controlled trials (RCTs) using a vehicle control design involving participants with a mycological diagnosis of a dermatophyte infection of the skin of the foot were included.

RESULTS: Allylamines, azoles, ciclopiroxolamine, tolnaftate, butenafine and undecanoates were all more effective than vehicle controls. Evidence of the superiority of azole creams over vehicle controls was fairly consistent from 1975 onwards. Data from patients treated with allylamines have shown their superior effects relative to vehicle controls since 1991 for even short-term outcomes.

CONCLUSIONS: The superiority of allylamines and azoles over vehicle in vehicle-controlled trials has been well established, and data demonstrating this fact have been available since the completion of early RCTs. These preparations are effective and safe, and investigators of RCTs evaluating topical treatments for athlete's foot need to choose potential comparators as control interventions in the light of this knowledge and to consider the ethics of withholding effective treatment from patients who seek treatment for this common foot infection.
Click to expand...

Admin2 · Oct 8, 2008

Related threads:
Other threads tagged with fungal infection

Craig Payne · Oct 9, 2008

NewsBot said: ↑

CONCLUSIONS: The superiority of allylamines and azoles over vehicle in vehicle-controlled trials has been well established, and data demonstrating this fact have been available since the completion of early RCTs. These preparations are effective and safe, and investigators of RCTs evaluating topical treatments for athlete's foot need to choose potential comparators as control interventions in the light of this knowledge and to consider the ethics of withholding effective treatment from patients who seek treatment for this common foot infection.
Click to expand...

This reminds me of what we have discussed before in the context of wound dressings research. How ethical is it to do a study on a new wound dressing, comparing that dressing to a "standard" treatment, when that "standard" treament consists of a saline dressing. Who still uses that?

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

Craig Payne Moderator

What is it like being randomized to the placebo or wait-and-see groups in research?

Placebo for heel pain

Placebo Mechanisms of Manual Therapy: A Sheep in Wolf 's Clothing?

Nifedipine Vs Placebo For Treatment Of Chilblains

Sham or placebo foot orthotics for use in clinical trials

Do cultures influence placebo response?

The power of the Placebo

Share This Page